<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000044824">
  <TermName>glycinamide ribonucleotide formyltransferase inhibitor</TermName>
  <TermPronunciation>(gly-SIH-nuh-mide RY-boh-NOO-klee-oh-tide FOR-mil-TRANZ-feh-rays in-HIH-bih-ter)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that blocks DNA synthesis and may prevent tumor growth. It is being studied as a treatment for cancer.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000706029" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;glycinamide ribonucleotide formyltransferase inhibitor&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000706030" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de glicinamida ribonucleótida formiltransferasa&quot;" language="es" id="_4"/>
  <SpanishTermName>inhibidor de glicinamida ribonucleótida formiltransferasa</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que bloquea la síntesis del ADN y que puede prevenir el crecimiento de tumores. Se encuentra en estudio para el tratamiento de cáncer.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2003-06-09</DateLastModified>
</GlossaryTerm>
